Importance of Chromosomal Changes Correlated to Prognostic Factors in
Ovarian and Cervical Malignant Tumors
Jančárková N.1, Krkavcová M.2, Janashia M.2, Freitag P.1, Dušková J.3, Cibula D.1
1Gynekologicko–porodnická klinika 1. LF UK a VFN, Praha, Onkogynekologické centrum, přednosta prof. MUDr. A. Martan, DrSc.2Ústav biologie a lékařské genetiky 1. LF UK a VFN, Praha, přednostka doc. MUDr. M. Kohoutová, CSc. 3Ústav patologie 1. LF UK a VFN, Praha, přednosta prof. MUDr. C. Povýšil, DrSc. |
|
Summary:
Objective: The aim of the study was to estimate genetic changes detected in ovarian and cervical cancer
cells, in correlation with other available clinical and histopathological parameters, with impact upon
cancer prognosis.
Design: Original article.
Setting: Department of Gynecology and Obstetrics, First Faculty of Medicine, Charles University in
Prague and General Teaching Hospital, Prague.
Methods: Sixty patients with ovarian cancer and twenty patients with cervical cancer were included in
the study. A histopathologist examined the tumor samples in order to define the histological type and
grade. MIB-1 and p53 were estimated using an immunohistochemical method. For genetic testing, both
conventional and molecular methods were applied (direct culture and a G-banding technique, the FISH
method with whole chromosome painting probes, and the CGH method). The results were submitted to
statistical evaluation, using analysis of variances and χ2 test.
Results. Numerical and structural chromosomal aberrations were detected in more than 63% of the
examined ovarian cancer cases and 29% of examined cervical cancer cases. Ovarian cancer patients with
extensive chromosomal rearrangements were significantly younger. The most typical findings in ovarian
cancer cells were amplifications 1q, 3q, 20q; and deletions 4p, 4q, 18p, 18q, 19q. The most typical findings
in cervical tumor cells were amplifications 3q, 5p; and deletions 13q and isochromosome 5p. Some of the
less frequent findings in our study were deletion 22q in 36% of all ovarian cancer samples, as well as
amplifications of chromosome 2 and deletions of chromosome 10, 11p, 21q in cervical cancer cells. The
activity of proliferative marker MIB-1 was significantly higher in women with a high p53 HSCORE
(p < 0.01).
Conclusions. Chromosomal rearrangements, different for ovarian and cervical cancer, have been found,
including several rare findings. The significant importance of genetic alterations and the activity of
proliferative markers, including common correlations with an unfavorable outcome in ovarian tumors of
younger women were found.
Key words:
ovarian cancer, cervical cancer, chromosomal rearrangements, prognostic factors
|